Ted Skolarus to Retrospective Studies
This is a "connection" page, showing publications Ted Skolarus has written about Retrospective Studies.
Connection Strength
0.988
-
Survival by first-line therapy and prognostic group among men with metastatic castration-resistant prostate cancer. Cancer Med. 2024 Jun; 13(12):e7334.
Score: 0.088
-
National Long-term Survival Estimates After Radical Prostatectomy for Prostate Cancer. Urology. 2024 02; 184:135-141.
Score: 0.085
-
The implications of baseline bone-health assessment at initiation of androgen-deprivation therapy for prostate cancer. BJU Int. 2018 04; 121(4):558-564.
Score: 0.056
-
No Differences in Population-based Readmissions After Open and Robotic-assisted Radical Cystectomy: Implications for Post-discharge Care. Urology. 2017 06; 104:77-83.
Score: 0.053
-
Variation in readmission expenditures after high-risk surgery. J Surg Res. 2017 06 01; 213:60-68.
Score: 0.053
-
Treatment of ureteral anastomotic strictures with reimplantation and survival after cystectomy and urinary diversion. Urol Oncol. 2017 01; 35(1):33.e1-33.e9.
Score: 0.052
-
The Fate of Radical Cystectomy Patients after Hospital Discharge: Understanding the Black Box of the Pre-readmission Interval. Eur Urol Focus. 2018 09; 4(5):711-717.
Score: 0.051
-
Intravesical bacille Calmette-Guérin therapy for non-muscle-invasive bladder cancer: effects of concurrent statin therapy. J Am Coll Surg. 2009 Aug; 209(2):248-53.
Score: 0.031
-
The distribution of histological subtypes of renal tumors by decade of life using the 2004 WHO classification. J Urol. 2008 Feb; 179(2):439-43; discussion 443-4.
Score: 0.028
-
Social vulnerability is associated with advanced breast cancer presentation and all-cause mortality: a retrospective cohort study. Breast Cancer Res. 2024 Dec 03; 26(1):176.
Score: 0.023
-
Determinants of Bone-Modifying Agent Prescribing for Metastatic Castration-Resistant Prostate Cancer in a National Health Care Delivery System. JCO Oncol Pract. 2024 01; 20(1):59-68.
Score: 0.021
-
Outcomes of Hematuria Evaluation by Advanced Practice Providers and Urologists. Urology. 2023 08; 178:67-75.
Score: 0.021
-
Evaluation of emergency department treat-and-release encounters after major gastrointestinal surgery. J Surg Oncol. 2023 Aug; 128(2):402-408.
Score: 0.020
-
Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries. Eur Urol. 2023 05; 83(5):393-401.
Score: 0.020
-
Development and Validation of a Short Version of the Metric for the Observation of Decision-Making in Multidisciplinary Tumor Boards: MODe-Lite. Ann Surg Oncol. 2021 Nov; 28(12):7577-7588.
Score: 0.018
-
Variations in Persistent Use of Low-Value Breast Cancer Surgery. JAMA Surg. 2021 04 01; 156(4):353-362.
Score: 0.018
-
Adherence and out-of-pocket costs among Medicare beneficiaries who are prescribed oral targeted therapies for advanced prostate cancer. Cancer. 2020 12 01; 126(23):5050-5059.
Score: 0.017
-
Resurrecting immortal-time bias in the study of readmissions. Health Serv Res. 2020 04; 55(2):273-276.
Score: 0.016
-
Comparison of Neoadjuvant and Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer. Clin Genitourin Cancer. 2020 06; 18(3):201-209.e2.
Score: 0.016
-
Association Between Hospital Participation in Medicare Shared Savings Program Accountable Care Organizations and Readmission Following Major Surgery. Ann Surg. 2019 05; 269(5):873-878.
Score: 0.016
-
Trends and appropriateness of perioperative chemotherapy for muscle-invasive bladder cancer. Urol Oncol. 2019 07; 37(7):462-469.
Score: 0.016
-
Role of Post-Acute Care on Hospital Readmission After High-Risk Surgery. J Surg Res. 2019 02; 234:116-122.
Score: 0.015
-
Population Analysis of Male Urethral Stricture Management and Urethroplasty Success in the United States. Urology. 2019 01; 123:258-264.
Score: 0.015
-
Association of the Hospital Readmissions Reduction Program With Surgical Readmissions. JAMA Surg. 2018 03 01; 153(3):243-250.
Score: 0.014
-
Urologist Practice Affiliation and Intensity-modulated Radiation Therapy for Prostate Cancer in the Elderly. Eur Urol. 2018 04; 73(4):491-498.
Score: 0.014
-
Sharp Decline In Prostate Cancer Treatment Among Men In The General Population, But Not Among Diagnosed Men. Health Aff (Millwood). 2017 01 01; 36(1):108-115.
Score: 0.013
-
Potential Implications of Shortening Length of Stay Following Radical Cystectomy in a Pre-ERAS Population. Urology. 2017 04; 102:92-99.
Score: 0.013
-
Implications of evolving delivery system reforms for prostate cancer care. Am J Manag Care. 2016 Sep; 22(9):569-75.
Score: 0.013
-
Health Care Integration and Quality among Men with Prostate Cancer. J Urol. 2017 01; 197(1):55-60.
Score: 0.013
-
Negative information-seeking experiences of long-term prostate cancer survivors. J Cancer Surviv. 2016 12; 10(6):1089-1095.
Score: 0.013
-
A Model to Optimize Followup Care and Reduce Hospital Readmissions after Radical Cystectomy. J Urol. 2016 May; 195(5):1362-1367.
Score: 0.012
-
Expectant management of veterans with early-stage prostate cancer. Cancer. 2016 Feb 15; 122(4):626-33.
Score: 0.012
-
Veterans Affairs Telemedicine: Bringing Urologic Care to Remote Clinics. Urology. 2015 Aug; 86(2):255-60.
Score: 0.012
-
Technology diffusion and prostate cancer quality of care. Urology. 2014 Nov; 84(5):1066-72.
Score: 0.011
-
Understanding the relationship between tumor size, gland size, and disease aggressiveness in men with prostate cancer. Urology. 2014 Aug; 84(2):373-8.
Score: 0.011
-
Adherence to performance measures and outcomes among men treated for prostate cancer. J Urol. 2014 Sep; 192(3):743-8.
Score: 0.011
-
Validating electronic cancer quality measures at Veterans Health Administration. Am J Manag Care. 2014; 20(12):1041-7.
Score: 0.011
-
Regional variation in quality of prostate cancer care. J Urol. 2014 Apr; 191(4):957-62.
Score: 0.011
-
Use of advanced treatment technologies among men at low risk of dying from prostate cancer. JAMA. 2013 Jun 26; 309(24):2587-95.
Score: 0.010
-
Technology diffusion and diagnostic testing for prostate cancer. J Urol. 2013 Nov; 190(5):1715-20.
Score: 0.010
-
Certificate of need regulations and the diffusion of intensity-modulated radiotherapy. Urology. 2012 Nov; 80(5):1015-20.
Score: 0.010
-
Identifying better practices for early-stage bladder cancer. Med Care. 2011 Dec; 49(12):1112-7.
Score: 0.009
-
Percent microscopic tumor necrosis and survival after curative surgery for renal cell carcinoma. J Urol. 2010 Mar; 183(3):909-14.
Score: 0.008
-
Transobturator sling with intraoperative cough test is effective for patients with low valsalva leak point pressure. Can J Urol. 2008 Aug; 15(4):4153-7.
Score: 0.007